What is the Impact Factor of Hepatic Medicine-Evidence and Research?

According to the latest Clarivate Journal Citation Reports (JCR), the Journal Impact Factor of Hepatic Medicine-Evidence and Research is 2.50, ranking in quartile Q3 of Web of Science (ESCI).

Is Hepatic Medicine-Evidence and Research indexed in Web of Science or Scopus?

Yes, Hepatic Medicine-Evidence and Research is indexed in Web of Science (ESCI, Q3 quartile). Furthermore, in Scopus (SCImago), it holds an SJR rating of N/A (Q3) and an H-index of N/A.

Who publishes Hepatic Medicine-Evidence and Research and what is the Article Processing Charge (APC)?

Hepatic Medicine-Evidence and Research is published by Dove Medical Press. For exact article processing charges and subscription guidelines, consult the official editorial guidelines.

WoS ESCI Q3Hybrid

Hepatic Medicine-Evidence and Research

Identifier (ISSN):1179-1535(Print)

•

Publisher:Dove Medical Press

Clarivate JCR Index Advisory: Active (ESCI)

Official Website Submission Portal Compare

Clarivate IF (2026)

2.5↑ +0.7

Journal Impact Factor

IF Trend↓

WoS Quartile

WoS ESCIJCR Quartile

Clarivate WoS JCR

WoS Categories↓

JCR Release Date: 2026-06-17

Impact Factor Trend (2023–2026)

Clarivate IF trend for Hepatic Medicine-Evidence and Research

WoS Q3

Annual Impact Factor Metric

Current (2026):2.5

Scopus SJR & Rank

N/A

SCImago Journal Rank citation prestige weighting

Scopus / Elsevier Data

H-Index (Hirsch Index)

N/A

papers with at least that number of citations each

WoS: ESCIQ3

Self-Citation Rate0%

Safe Level (< 15%)Warning Level (> 20%)

Self-citation below 15% indicates strong scholarly independence.

Volume & Open AccessHybrid

13articles/year

97.73% Gold OA•58.33% Original Research

Aims & Scope

Hepatic Medicine: Evidence and Research is an international, peer-reviewed, open access, online journal. Publishing original research, reports, editorials, reviews and commentaries on all aspects of adult and pediatric hepatology in the clinic and laboratory including the following topics: Pathology, pathophysiology of hepatic disease Investigation and treatment of hepatic disease Pharmacology of drugs used for the treatment of hepatic disease Although the main focus of the journal is to publish research and clinical results in humans; preclinical, animal and in vitro studies will be published where they will shed light on disease processes and potential new therapies. Issues of patient safety and quality of care will also be considered. As of 1st April 2019, Hepatic Medicine: Evidence and Research will no longer consider meta-analyses for publication.

Topics Covered (Recognized by AI)

Medicine97%Internal medicine95.2%Biology90.5%Genetics69.6%Gastroenterology64.3%Pathology64.3%Chemistry61.9%Biochemistry61.3%Immunology51.2%Surgery46.4%Cirrhosis42.3%Virology37.5%Virus32.7%Endocrinology28%Disease28%Liver disease26.8%Gene23.2%Hepatitis C virus23.2%Physics22%

Primary Research Areas

Gastroenterology & Hepatology

Official Website NLM PubMed Catalog

0 calls

Special Issues

Calls for Papers

No active Calls for Papers found for this journal.

Expand

WoS Categories & Quartiles

Detailed JCR / JCI category rankings and quartile breakdown from Clarivate

Clarivate JCR & JCI

JCRESCI2026

GASTROENTEROLOGY & HEPATOLOGY

Rank85/153

IndexESCI

JCIESCI2026

GASTROENTEROLOGY & HEPATOLOGY

Rank102/153

IndexESCI

Category	Index	Rank	Quartile
GASTROENTEROLOGY & HEPATOLOGY	JCRESCI	85/153	Q3
GASTROENTEROLOGY & HEPATOLOGY	JCIESCI	102/153	Q3

Annual Historical Statistics & Publications

Track annual publication volume, total citations, and Impact Factor evolution

12 year

2026Latest

IF2.5

Articles / Year3

Total Citations0

2025

IF1.8

Articles / Year15

Total Citations13

2024

IF2.6

Articles / Year10

Total Citations28

2023

IF2.1

Articles / Year22

Total Citations146

2022

IF—

Articles / Year13

Total Citations140

Year	Impact Factor	Articles / Year	Total Citations
2026	2.5	3	0
2025	1.8	15	13
2024	2.6	10	28
2023	2.1	22	146
2022	—	13	140
2021	—	17	316
2020	—	16	271
2019	—	15	431
2018	—	14	429
2017	—	10	401
2016	—	15	685
2015	—	8	233

SCImago & Scopus Journal Intelligence

Not indexed in SCImago / Scopus database

This journal is currently not indexed in Scopus or is an academic publication indexed exclusively in Web of Science (WoS).

Academic Metric Intelligence

Journal Metrics & Citation Visualizations

Total Cites vs Self-Cites

Evaluation of scholarly independence and citation reach

Total citations steady growth

Self-citation: 0%

Citations per Document

Citation metric windows across 2, 3, and 4 years

Cites / Doc (4 years)Cites / Doc (3 years)Cites / Doc (2 years)

Chinese Academy of Sciences (CAS) Classification

Major / minor zone classification and CAS Early Warning List history

Major Category (Broad Field):

4区 (Zone 4)Medicine

Minor Category (Specific Field):

4区GASTROENTEROLOGY & HEPATOLOGY

CAS Early Warning List History:

Updated annually: 2020 – 2024

2020

Not warned

2021

Not warned

2022

Not warned

2023

Not warned

2024

Not warned

Academic Intelligence Overview & Context

ImpaQ Analysis

Hepatic Medicine-Evidence and Research (ISSN: 1179-1535) is a peer-reviewed international scholarly journal in the field of GASTROENTEROLOGY & HEPATOLOGY, published by Dove Medical Press in United Kingdom. The periodical holds a Journal Impact Factor (JIF) of 2.50, ranking in quartile Q3 of Web of Science (ESCI).

The journal enforces rigorous peer evaluation with an annual output of approximately 13 scientific articles. In terms of accessibility and author fees, it operates under the Hybrid model with APC fees are not specified. It serves as a benchmark publication platform for academics, researchers, and doctoral candidates seeking global research visibility.